Stamford, CT -- (SBWIRE) -- 01/02/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Vista Gold Corp. (NYSEMKT:VGZ), BIOLASE Inc (NASDAQ:BIOL), Star Scientific, Inc. (NASDAQ:STSI), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Vista Gold Corp. (NYSEMKT:VGZ) opened the session at $0.41, trading in a range of $0.38 - $0.44,. The stock showed a negative performance of -9.50% in the last trading session from its previous close of $0.42 and closed at $0.380. The stock traded on a volume of 1.14 million shares and the average volume of the stock remained 466,770 shares. Vista Gold Corp. focuses on the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects primarily in Australia, North America, and Indonesia. The company focuses on the development of the Mt. Todd gold project in Northern Territory, Australia. Its properties also include the Guadalupe de los Reyes gold/silver project in Mexico; the Los Cardones gold project in Mexico; the Awak Mas gold project in Indonesia; the Long Valley gold project in California; and mining claims in Utah. Vista Gold Corp. was founded in 1983 and is based in Littleton, Colorado.
Has VGZ Found The Bottom and Ready To Move Up? Find Out Here
BIOLASE Inc (NASDAQ:BIOL) traded 1.25 million shares in the last business day while the average volume of the stock remained 501,508 shares. The stock showed a negative movement of -7.52% to end at $2.83. The 52 week range of the stock remained $1.15 - $5.96. BIOLASE, Inc., a biomedical company, develops, manufactures, and markets lasers in dentistry and medicine in the Unites States and internationally. The company offers Waterlase systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications.
Has BIOL Found The Bottom And Ready To Gain Momentum? Find Out Here
Star Scientific, Inc. (NASDAQ:STSI) reported 4.75 million shares were exchanged during the last trade, while the average volume is about 1.21 million shares. The stock dropped -7.20% and finished the day at $1.16. The beta of the stock is recorded at 2.36. Star Scientific, Inc. engages in the development, manufacture, sale, and marketing of nutraceutical dietary supplements and consumer products. The company offers non-nicotine nutraceutical and dietary supplements, including Anatabloc for anti-inflammatory support, and CigRx for fighting the urge to smoke cigarettes. It also provides Anatabloc Facial Crème, an anatabine citrate based face cream to enhance the appearance of the skin; and other nutraceuticals, dietary supplements, and pharmaceutical products, which have a botanical-based component and designed to treat a range of conditions, including Alzheimer?s disease, Parkinson?s disease, multiple sclerosis, schizophrenia, depression, and tobacco dependence.
Why Should Investors Buy STSI After the Recent Fall? Just Go Here and Find Out
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) shares dropped -5.61 percent from its previous close of $0.98 to close at $0.925. Traded with volume of 3.72 million shares in the prior session and the average volume of the stock remained 4.02 million shares. ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, engages in developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumors. Its lead pipeline product is ICT-107, a therapeutic dendritic cell (DC) vaccine, which is in Phase IIb clinical trial for the treatment of glioblastoma multiforme (GBM) that is a common and lethal type of brain cancer.
Will IMUC Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)